Due to the severe adverse effects that can accompany conventional therapies for Crohn's disease, the search for natural complementary therapies has increased dramatically in recent years. Indole-3-carbinol (I3C), a constituent of cruciferous vegetables, possesses anti-inflammatory properties; however, its effects on intestinal inflammation have yet to be evaluated. To test the hypothesis that I3C dampens intestinal inflammation, C57B1/6 mice were treated with I3C and exposed to 2,4,6-trinitrobenzenesulfonic acid (TNBS) to induce colitis. Several parameters of disease severity and inflammation were subsequently evaluated. I3C dampened the disease severity, as indicated by decreased body weight loss and decreased severity of clinical signs. Interestingly, this effect was observed in female but not male mice, which displayed a trend towards exacerbated colitis. Differential effects were observed in the profiles of cytokine production, as the production of pro-inflammatory cytokines was increased in males. The sex-specific effect of I3C in TNBS-induced colitis is a novel finding and warrants further investigation since this is a common dietary compound and is also available commercially.
AdlerSRashidGKleinA. Indole-3-carbinol inhibits telomerase activity and gene expression in prostate cancer cell lines. Anticancer Res2011; 31:3733–7.
2.
AhmadASakrWARahmanKM. Novel targets for detection of cancer and their modulation by chemopreventive natural compounds. Front Biosci (Elite Ed)2012; 4:410–25.
3.
KimSYKimaDSJeongYMMoonSIKwonSBParkKC. Indole-3-carbinol and ultraviolet B induce apoptosis of human melanoma cells via down-regulation of MITF. Pharmazie2011; 66:982–7.
4.
MarconettCNSinghaiAKSundarSNFirestoneGL. Indole-3-Carbinol disrupts Estrogen Receptor-alpha dependent expression of Insulin-like Growth Factor-1 Receptor and Insulin Receptor Substrate-1 and proliferation of human breast cancer cells. Mol Cell Endocrinol2012.
5.
AggarwalBBIchikawaH. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle2005; 4:1201–15.
6.
BradlowHLMichnoviczJJHalperMMillerDGWongGYOsborneMP. Long-term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidemiol Biomarkers Prev1994; 3:591–5.
7.
ReedGAPetersonKSSmithHJGrayJCSullivanDKMayoMSCrowellJAHurwitzA. A phase I study of indole-3-carbinol in women: Tolerability and effects. Cancer Epidemiol Biomarkers Prev2005; 14:1953–60.
8.
WongGYBradlowLSepkovicDMehlSMailmanJOsborneMP. Dose-ranging study of indole-3-carbinol for breast cancer prevention. J Cell Biochem Suppl1997; 28–29:111–6.
VogelCFSciulloEMatsumuraF. Involvement of RelB in aryl hydrocarbon receptor-mediated induction of chemokines. Biochem Biophys Res Commun2007; 363:722–6.
11.
VogelCFSciulloELiWWongPLazennecGMatsumuraF. Re1B, a new partner of aryl hydrocarbon receptor-mediated transcription. Mol Endocrinol2007; 21:2941–55.
12.
OhtakeFTakeyamaKMatsumotoTKitagawaHYamamotoYNoharaKTohyamaCKrustAMimuraJChambonPYanagisawaJFujii-KuriyamaYKatoS. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature2003; 423:545–50.
13.
MatthewsJWihlenBThomsenJGustafssonJA. Aryl hydrocarbon receptor-mediated transcription: Ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol Cell Biol2005; 25:5317–28.
14.
WormkeMStonerMSavilleBWalkerKAbdelrahimMBurghardtRSafeS. The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes. Mol Cell Biol2003; 23:1843–55.
15.
TakadaYAndreeffMAggarwalBB. Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood2005; 106:641–9.
16.
ChangHPWangMLHsuCYLiuMEChanMHChenYH. Suppression of inflammation-associated factors by indole-3-carbinol in mice fed high-fat diets and in isolated, co-cultured macrophages and adipocytes. Int J Obes (Lond)2011.
17.
TsaiJTLiuHCChenYH. Suppression of inflammatory mediators by cruciferous vegetable-derived indole-3-carbinol and phenylethyl isothiocyanate in lipopolysaccharide-activated macrophages. Mediators Inflamm2010; 2010:293642.
18.
BensonJMShepherdDM. Dietary ligands of the aryl hydrocarbon receptor induce anti-inflammatory and immunoregulatory effects on murine dendritic cells. Toxicol Sci2011; 124:327–38.
19.
KimYHKwonHSKimDHShinEKKangYHParkJHShinHKKimJK. 3,3′-diindolylmethane attenuates colonic inflammation and tumorigenesis in mice. Inflamm Bowel Dis2009; 15:1164–73.
20.
BensonJMShepherdDM. Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease. Toxicol Sci2011; 120:68–78.
21.
21. MinichDMBlandJS. A review of the clinical efficacy and safety of cruciferous vegetable phytochemicals. Nutr Rev2007; 65:259–67.
22.
ChoHJSeonMRLeeYMKimJKimJKKimSGParkJH. 3,3′-Diindolylmethane suppresses the inflammatory response to lipopolysaccharide in murine macrophages. J Nutr2008; 138:17–23.
23.
ZhangZZhengMBindasJSchwarzenbergerPKollsJK. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis2006; 12:382–8.
24.
FeaginsLA. Role of transforming growth factor-beta in inflammatory bowel disease and colitis-associated colon cancer. Inflamm Bowel Dis2010; 16:1963–8.
25.
IzcueACoombesJLPowrieF. Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol2009; 27:313–38.
26.
Sanchez-MunozFDominguez-LopezAYamamoto-FurushoJK. Role of cytokines in inflammatory bowel disease. World J Gastroenterol2008; 14:4280–8.
27.
KornT. How T cells take developmental decisions by using the aryl hydrocarbon receptor to sense the environment. Proc Natl Acad Sci U S A2010; 107:20597–8.
28.
QuintanaFJBassoASIglesiasAHKornTFarezMFBettelliECaccamoMOukkaMWeinerHL. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature2008; 453:65–71.
29.
QuintanaFJMurugaiyanGFarezMFMitsdoerfferMTukpahAMBurnsEJWeinerHL. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA2010; 107:20768–73.
